JPMorgan Chase & Co. 13D and 13G filings for Karyopharm Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-16 09:34 am Purchase | 2025-06-30 | 13G | Karyopharm Therapeutics Inc. KPTI | JPMORGAN CHASE & CO JPM | 450,436 5.200% | 450,436 (New Position) | Filing |